Search

iRhythm Technologies Inc

Затворен

СекторЗдравеопазване

121.81 -2.25

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

120.35

Максимум

124.68

Ключови измерители

By Trading Economics

Приходи

14M

-381K

Продажби

25M

224M

EPS

0.58

Марж на печалбата

-0.17

Служители

2,400

EBITDA

6.5M

2.9M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+26.71% upside

Дивиденти

By Acuity

Следващи печалби

29.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

16M

4.1B

Предишно отваряне

124.06

Предишно затваряне

121.81

Настроения в новините

By Acuity

7%

93%

3 / 340 Класиране в Healthcare

iRhythm Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.08.2026 г., 20:06 ч. UTC

iRhythm Technologies shares are lower today, continuing a downward trend since Monday's close, despite stabilizing above the 20-day moving average.

10.08.2026 г., 19:41 ч. UTC

News

iRhythm Technologies shares lower today despite Truist raising the price target to $168.00 and reporting Q2 sales of $224.2 million.

7.08.2026 г., 19:51 ч. UTC

News

iRhythm Technologies is higher today, driven by strong earnings of $224.17 million and its acquisition of VitalConnect for $287.5 million.

6.08.2026 г., 23:02 ч. UTC

News

iRhythm Technologies shares rise in after-market trading following strong Q2 results, $224.2 million in revenue, and an acquisition of VitalConnect for $287.5 million.

5.08.2026 г., 19:46 ч. UTC

News

iRhythm Technologies shares are lower amid cautious market sentiment following ADP's report of disappointing private sector job growth. Earnings are due August 6.

4.08.2026 г., 21:01 ч. UTC

iRhythm Technologies Inc shares rose in after-market hours, reflecting a broader market rally amid positive sentiment from U.S.-Iran negotiations and falling crude oil prices.

3.08.2026 г., 20:03 ч. UTC

iRhythm Technologies Inc shares are rising, driven by gains in the Health Care Equipment sub-sector and overall strong market performance.

31.07.2026 г., 21:01 ч. UTC

iRhythm Technologies Inc shares advanced in after-hours trading, reflecting unusual strength amid rising inflation concerns and geopolitical tensions affecting oil prices.

30.07.2026 г., 19:43 ч. UTC

iRhythm Technologies Inc is lower today, influenced by declines in the Health Care Equipment sub-sector. This follows five consecutive sessions of gains.

29.07.2026 г., 19:52 ч. UTC

Macro Event

iRhythm Technologies shares are higher today, reflecting positive momentum after the Federal Reserve maintained interest rates amid easing inflation concerns.

28.07.2026 г., 18:03 ч. UTC

iRhythm Technologies is higher today, driven by gains in the Health Care Equipment sub-sector. Shares pulled back from earlier session highs.

27.07.2026 г., 20:06 ч. UTC

iRhythm Technologies Inc shares are higher amid positive market sentiment, driven by a decline in oil prices and easing geopolitical tensions.

24.07.2026 г., 20:06 ч. UTC

iRhythm Technologies Inc shares are trading higher, reflecting positive sentiment amid falling oil prices that ease inflation concerns. No specific company news was identified.

23.07.2026 г., 09:01 ч. UTC

iRhythm Technologies Inc is trading higher in pre-market hours, reflecting a notable gain since Wednesday's close. No specific news was identified for this movement.

21.07.2026 г., 18:56 ч. UTC

News

iRhythm Technologies is under investigation for potential wrongdoing by certain officers and directors, contributing to lower trading during Tuesday's session.

20.07.2026 г., 19:16 ч. UTC

iRhythm Technologies Inc is trading higher Monday, having reached a peak cumulative return earlier in the session. No specific news was identified to explain the movement.

Сравнение с други в отрасъла

Ценова промяна

iRhythm Technologies Inc Прогноза

Ценова цел

By TipRanks

26.71% нагоре

12-месечна прогноза

Среден 158.11 USD  26.71%

Висок 196 USD

Нисък 18 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за iRhythm Technologies Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

11

Купи

0

Задържане

0

Продай

Настроение

By Acuity

3 / 340 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat